CL2007003162A1 - Uso de compuestos derivados de vitamina d para prevenir, tratar o aminorar un desorden hiperproliferativo. - Google Patents

Uso de compuestos derivados de vitamina d para prevenir, tratar o aminorar un desorden hiperproliferativo.

Info

Publication number
CL2007003162A1
CL2007003162A1 CL200703162A CL2007003162A CL2007003162A1 CL 2007003162 A1 CL2007003162 A1 CL 2007003162A1 CL 200703162 A CL200703162 A CL 200703162A CL 2007003162 A CL2007003162 A CL 2007003162A CL 2007003162 A1 CL2007003162 A1 CL 2007003162A1
Authority
CL
Chile
Prior art keywords
vitamin
treat
damage
prevent
compounds derived
Prior art date
Application number
CL200703162A
Other languages
English (en)
Inventor
John G Curd
Original Assignee
Novacea Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacea Inc filed Critical Novacea Inc
Publication of CL2007003162A1 publication Critical patent/CL2007003162A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
CL200703162A 2006-11-01 2007-10-31 Uso de compuestos derivados de vitamina d para prevenir, tratar o aminorar un desorden hiperproliferativo. CL2007003162A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86390906P 2006-11-01 2006-11-01
US96816007P 2007-08-27 2007-08-27

Publications (1)

Publication Number Publication Date
CL2007003162A1 true CL2007003162A1 (es) 2008-05-30

Family

ID=39365038

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703162A CL2007003162A1 (es) 2006-11-01 2007-10-31 Uso de compuestos derivados de vitamina d para prevenir, tratar o aminorar un desorden hiperproliferativo.

Country Status (3)

Country Link
CL (1) CL2007003162A1 (es)
TW (1) TW200833345A (es)
WO (1) WO2008057363A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011079249A2 (en) * 2009-12-23 2011-06-30 Glycomyr, Inc. Use of vitamin d glycosides and sulfates for treatment of disease
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CA2909941A1 (en) 2013-04-24 2014-10-30 Salk Institute For Biological Studies Vitamin d receptor/smad genomic circuit gates fibrotic response
EP3473299A1 (en) 2013-06-05 2019-04-24 Salk Institute for Biological Studies Vitamin d receptor agonists to treat diseases involving cxcl12 activity
WO2019023149A1 (en) 2017-07-24 2019-01-31 Salk Institute For Biological Studies USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES
CA3169406A1 (en) 2020-01-28 2021-08-05 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
EP2340840B1 (en) * 1998-03-27 2012-08-29 Oregon Health Sciences University Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
DK1411951T4 (da) * 2001-07-27 2010-12-20 Nutricia Nv Enteralt præparat til forebyggelse og/eller behandling af sepsis
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US20060078494A1 (en) * 2004-09-24 2006-04-13 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer

Also Published As

Publication number Publication date
WO2008057363A3 (en) 2008-08-14
WO2008057363A2 (en) 2008-05-15
TW200833345A (en) 2008-08-16

Similar Documents

Publication Publication Date Title
BRPI0922475A2 (pt) composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0923325A2 (pt) métodos para usar um composto, e para suprimir a produção deum composto de isocianato livre.
CL2008000754A1 (es) Compuesto derivado de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar cancer y trastornos hiperproliferativos.
BRPI0815717A2 (pt) Compostos de imidazopirazina.
BRPI1008498A2 (pt) Composto, prodroga do composto, medicamento, e, uso de um composto.
CR10353A (es) Nuevos compuestos.
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
NL2000527A1 (nl) Dibenzylamine-verbindingen en -derivaten.
BRPI0908100A2 (pt) produto combinação, uso de um composto, e, método de tratar câncer
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0813438A2 (pt) Processo para preparar um composto, uso de um composto, e, composto.
CL2007003162A1 (es) Uso de compuestos derivados de vitamina d para prevenir, tratar o aminorar un desorden hiperproliferativo.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BRPI0718324A2 (pt) Métodos para o tratamento de depressão.
BRPI0917147A2 (pt) composto ou sal deste, uso de um composto ou sal deste, e, processo para fabricar um composto.
ES1059722Y (es) Cuerda para elementos de proteccion individual.
BRPI0916847A2 (pt) preparação sólida, e, métodos para estabilizar um composto e para melhorar a propriedade de dissolução de um composto.
BRPI0914248A2 (pt) Processos para a hidrogenólise de um derivado de furfurila e para a preparação de um derivado de 2-metilfurano.
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
BRPI0818422A2 (pt) Processo para a preparação de melamina.
BRPI0814581A2 (pt) processo para a preparação de um composto, e, composto.
BRPI0807853A2 (pt) Prendedor para vestuário.
NL2000514A1 (nl) Dibenzylamine-verbindingen en -derivaten.
BRPI0913586A2 (pt) combinação, uso de combinação, método para tratar, inibir ou prevenir uma doença ou condição.
BRPI0819653A2 (pt) Método para a produção de um composto de tetrapirrol, e, composto de tetrapirrol.